Skip to the page

Data / Form D filings / CIRC Biosciences, Inc.

CIRC Biosciences, Inc.: Form D filings

CIRC Biosciences, Inc., a biotechnology company in Chicago, IL, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on October 7, 2024, reports $250,000 sold of a $250,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
400 N. ABERDEEN, SUITE 900, Chicago, IL, 60642
Phone
(312) 847-1322
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1834514

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 7, 2024New notice$250,000$250,0001Feb 1, 2024sec.gov
May 1, 2024New notice$7,000,000$7,000,00019Apr 15, 2024sec.gov
Dec 7, 2020New notice$16,835,000$16,835,0003Oct 23, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Darien ParhadExecutive Officer
Timothy CunniffDirector
Patrick MorrisExecutive Officer, Director
Sai ChavalaDirector
Antonio GraciasDirector
Jeffrey AroninDirector

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Oct 7, 2024 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CIRC Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.